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A沼STRACT
Forty-nine medica1 schoo1 teachers (76% of 21 professors of pharmaco1ogy or clinica1 phar-
maco1ogy， and 51% of 65 counci1ors of the Society of ]apanese C1inica1 Pharmaco1ogy and 
Therapeutics) comp1eted questionnaire A. Thirty-three clinica1 doctors (四%of 175 gradu明
ates of the Tottori University， in1999 and 1991) comp1eted questionnaire B， and 46 investi-
gators (31 % of 150 principa1 and sub-investigators invo1ved in clinica1 tria1s at Tottori 
University Hospital) comp1eted questionnaire C. The majority of the teachers agree with 
the concept of clinica1 pharmaco1ogy and therapeutics as the fundamenta1 science underlying 
pharmacotherapy， and that it contributes to the deve10pment of new drugs and provides ap-
propriate pharmacotherapy. The majority considered that the important points were: 1) un-
derstanding of clinica1 tria1s for new drugs， 2) paying attention not on1y to diagnosis but 
a1so treatment of diseases， 3)comprehension of clinica1 pharmaco1ogica1 prob1em solving， 4)
rationa1 prescribing. They a1so defined core know1edge as: concept of clinica1 pharmaco1ogy 
and therapeutics， clinica1 pharmacokinetics， adverse drug reaction， and drug interactions. 
Respondents a1so supported the use of drug therapy for cardiovascu1ar diseases as a suita-
b1e subject for a seminar. For practica1 training， informed consent， clinica1 appraisa1 of the 
drug effect， and pharmacokinetics were enumerated. Many teachers supported bedside 1earn-
ing and enrichment of postgraduate education of the clinica1 pharmaco1ogy and therapeutics. 
C1inica1 doctors in the second year and ten years after graduation from Tottori University 
expressed the image of clinica1 pharmaco1ogy and therapeutics and supported practica1 edu-
cation in clinica1 pharmaco1ogy during undergraduate as well as postgraduate seminars. 




pharmacological knowledge useful in completing trials， for example， appraisal method to d令
termine drug action， understanding of the significance of phases I-III of clinical trials for 
new drugs， good clinical practice (GCP) for clinical trials， preclinical experiments， the 
Declaration of Helsinki， ethical issues， and informed consent. They reported that many sub-
jects were already studied as an undergraduate， such as pharmacokinetics， adverse drug 
reaction， and drug interactions. However， they had not studied pharmacogenetics， 
chronopharmacology， general aspects of the development of new drugs， informed consent， 
ethical issues， and good clinical practices in trials. This finding shows that many of these 
respondents seemed to be rather old and/or graduates of other medical schools. 
From these results， itappeared that our intention has been accomplished under the previ-
ous educational plan. However， in the newly applied so一called“medicalcore curriculum" 
system in J apan， another pr・ogramshould be considered to support students' learning of 
clinical pharmacology and therapeutics to train safe and good practitioners. 
(Accepted on August 9， 2006) 
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鵠床薬理学の概念(総論) 88 12 
2. 臨床薬物動態学 82 18 
3. 薬物相互作用 78 22 
4. 薬物有害反応 78 22 
5. 老年者への薬物投与法 47 49 
6. 妊娠時の薬物投与法 45 49 
7. 新薬の開発・臨床試験 45 39 
8. 新生児・小児への投与法 37 57 
















































































































































































































































































































































































17. 薬剤選択法(剤形， DDS) 
TDM: Therapeutic drug monitoring， 
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